Your Web Site
Synageva BioPharma Appoints Leading Clinician and Industry Executive, Dr. Mark Goldberg, to Its...
Synageva BioPharma announced today the appointment of Mark Goldberg, M.D., Senior Vice President of Clinical Research at Genzyme Corp., and a leading medical oncologist and hematologist, to the Company's Board of Directors.

